What are the hidden risks in Pfizer stock?

Expiration of key drug patents and declining COVID vaccine revenue threaten earnings growth and could lead to dividend cuts.

Are McDonald's dividends safe?

Yes, McDonald's dividends are backed by stable cash flows and steady growth, making them safer.

McDonald's vs. Pfizer: Which Blue-Chip Dividend Stock Wins?

Both are blue-chip laggards trading at a discount with reliable dividends. But one carries hidden risks that could quietly wreck an income portfolio.

July 10, 2026

2 min read

Source: 24/7 Wall St.

According to an analysis by 24/7 Wall St., investors face a choice between McDonald's (MCD) and Pfizer (PFE), both blue-chip stocks trading at a discount with attractive dividends. However, the warning suggests one may be a dividend trap.

McDonald's: Real Growth or Just Compensation?

McDonald's offers earnings growth supported by global expansion and menu innovation, making it a real growth pick. Its stock trades at a discount to historical averages, offering value for investors.

Pfizer: High Yield with Hidden Risks

Pfizer offers a higher dividend yield, but this may simply compensate for weak growth. With key drug patents expiring and declining COVID vaccine revenue, Pfizer faces structural challenges that could lead to future dividend cuts.

Risk Comparison

McDonald's: Lower risk, steady growth, sustainable dividends.
Pfizer: Higher yield but with risks of earnings and dividend decline.

Conclusion

Income-seeking investors may prefer McDonald's for safety, while those chasing higher yield take on Pfizer's risks. No buy or sell recommendation, just risk and opportunity analysis.

Frequently Asked Questions

McDonald's offers more stable growth and lower risk, while Pfizer offers higher dividend yield but with hidden risks. The choice depends on investor goals.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.